Healio: Early data shows new treatment effective for pediatric Hodgkin lymphoma patients
UC expert presents clinical trial data at ASCO conference
A new combination treatment for patients with advanced-stage Hodgkin lymphoma is safe and effective in pediatric patients, according to early new clinical trial data.
Robin E. Norris, MD, associate professor in the University of Cincinnati Department of Pediatrics in the College of Medicine and director of clinical research for oncology and co-director of the young adult oncology program at Cincinnati Children's Hospital Medical Center, presented updated data from an ongoing phase 1/phase 2 clinical trial of a new combination treatment at the American Society of Clinical Oncology Annual Meeting in Chicago last week. The presentation was highlighted in a recent article by Healio.
The trial is studying the effectiveness of a drug called brentuximab vedotin, a combination immunotherapy and chemotherapy agent, with other chemotherapy regimens.
The drug has been FDA approved as a first-line therapy for adults, and the clinical trial has shown safety and effectiveness so far with patients aged 5-18.
“These safety and efficacy data are consistent with those seen in adult patients,” Norris said. “These findings support the use of brentuximab plus AVD as a reasonable option for pediatric patients with newly diagnosed, advanced-stage classical Hodgkin lymphoma."
Featured photo at top of human lymphoma tumor cells courtesy of the National Cancer Institute.
Local 12 News: How Supreme Court abortion ruling will impact...
June 25, 2022
Jenn Dye, PhD, director of the Theodore M. Berry Director of the Nathaniel R. Jones Center for Race, Gender, and Social Justice, spoke with Local 12 News about what a partisan divide that will emerge in the wake of the US Supreme Court reversing Roe V Wade. More conservative states are likely to ban abortion or make it extremely hard to obtain.
Cincinnati Edition: The Supreme Court overturns Roe v. Wade,...
June 24, 2022
Cincinnati Edition hosted a panel discussion about the U..S. Supreme Court decision overturning Roe v Wade and leaving the decision to permit or ban abortion to individual states. UC Law Dean Verna Williams was among the panelists.
Fox19: UC contributes to search for life on Mars
June 24, 2022
UC College of Arts and Sciences associate professor Andy Czaja and his students are on NASA's science team using the Perseverance rover and Ingenuity helicopter to look for evidence of ancient life on Mars.